2647441-36-7 (ATV006,ATV006)

D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate);SHEN26;Obeldesivir;CS-0498195;D-Altrononitrile, 2-C-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate);CHEMBL4863829;MS-25721;2647441-36-7;((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate;AKOS040758853;SCHEMBL23959875;GTPL12901;EX-A6600;ATV-006;BDBM670936;GS5245;UNII-Q55KCM7PXB;Obeldesivir [INN];DA-57831;2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D -altrononitrile 6-(2-methylpropanoate);Q55KCM7PXB;compound 5c [PMID: 34450570];2-C-(4-Aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-d -altrononitrile 6-(2-methylpropanoate);D12776;HY-145994;ATV006;Obeldesivir (JAN/USAN/INN);[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methyl 2-methylpropanoate;US20240140975, Compound A50;compound 5c (PMID: 34450570);Obeldesivir [WHO-DD];GS-5245;OBELDESIVIR [USAN];

YIHPGVCWGSURHO-VSBTWAGUSA-N

1S/C16H19N5O5/c1-8(2)15(24)25-5-10-12(22)13(23)16(6-17,26-10)11-4-3-9-14(18)19-7-20-21(9)11/h3-4,7-8,10,12-13,22-23H,5H2,1-2H3,(H2,18,19,20)/t10-,12-,13-,16+/m1/s1

C([C@]1(C2=CC=C3C(=NC=NN23)N)[C@@H]([C@H](O)[C@@H](COC(=O)C(C)C)O1)O)#N